NovaBiotics Ltd

NovaBiotics Ltd

Private
AberdeenHealthcare & Life Scienceshttps://novabiotics.co.uk/

Last Round

Grant

Oct 16, 2020

Total Funding Raised

$3.64M

Company Overview

NovaBiotics Ltd is a clinical-stage biotechnology company that designs and develops first-in-class therapies to address difficult-to-treat, medically unmet diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

antimicrobial resistanceAMRanti-infective therapiescystic fibrosis treatmentclinical-stage biotechdrug-resistant infectionssuperbug treatmentpeptide therapeuticsantibiotic potentiatororphan drug developmentantibiotic enhancementpharmaceutical licensingantifungal peptidesrespiratory disease therapyconsumer health productspodiatry products

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovaBiotics Ltd Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NovaBiotics Ltd Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 16, 2020
GrantFeb 18, 2019
Private PlacementJan 19, 2015
VC RoundMar 14, 2012

Key People

Founding team and executive leadership

Deborah O’Neil OBE FRSE

Chief Executive Officer

Executive Team

NovaBiotics Ltd Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors grew 1540% MoM, reaching 1K.

  • Feb 25, 2025

    Monthly visitors grew 92% MoM, from 626 to 1.2K.

NovaBiotics Ltd Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NovaBiotics Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NovaBiotics Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersAberdeen
Employee Range15
Year Founded2004
Last FundingOct 16, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.